<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02400840</url>
  </required_header>
  <id_info>
    <org_study_id>2013/153/HP</org_study_id>
    <nct_id>NCT02400840</nct_id>
  </id_info>
  <brief_title>Acute Heart Graft Rejection Screening by Cardiac Magnetic Resonance Imaging</brief_title>
  <acronym>DRAGON</acronym>
  <official_title>Acute Heart Graft Rejection Screening by Cardiac Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute heart allograft rejection is a common complication after orthotopic heart
      transplantation. Primary objective of this study is to assess cardiac MRI as a tool for acute
      heart graft rejection screening, by detecting changes in myocardium structure especially
      extracellular volume.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute heart allograft rejection is a common complication after orthotopic heart
      transplantation. It can lead to multiple cardiac injuries and sometimes to patient's death.
      Currently, acute heart graft rejection screening is based on invasive strategies. Gold
      standard is represented by endomyocardial biopsies which provide side effects risk, rare but
      potentially fatal for the recipient. Cardiac MRI is an imaging tool recently used in
      cardiology. It is a non-invasive without any X-Ray exposition method well adapted to assess
      cardiac function and cardiac muscle composition. Cardiac MRI is probably a great tool to help
      the screening of acute heart allograft rejection, by detecting changes in myocardium
      structure. MRI validation as a screening tool for heart allograft rejection detection could
      help to reduce endomyocardial biopsies realised after orthotopic heart transplantation.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Study is not feasable yet, due to evolution in the patients' care
  </why_stopped>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patient with an acute rejection detected using Cardiac MRI after orthotopic heart transplantation</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Extracellular volume as measured by Cardiac MRI</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>T1 as measured by Cardiac MRI</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>T2 as measured by Cardiac MRI</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Cardiac Graft</condition>
  <arm_group>
    <arm_group_label>Heart graft rejection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Assessment of cardiac allograft recipient with rejection by Cardiac MRI with gadobenic acid intravenous injection 0.2 ml/kg one time</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No rejection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Assessment of cardiac allograft recipient without any rejection by Cardiac MRI with gadobenic acid intravenous injection 0.2 ml/kg one time</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cardiac MRI</intervention_name>
    <description>Cardiac MRI is done using gadobenic acid intravenous injection 0.2 ml/kg one time</description>
    <arm_group_label>Heart graft rejection</arm_group_label>
    <arm_group_label>No rejection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>gadobenic acid intravenous injection 0.2 ml/kg</intervention_name>
    <description>gadobenic acid intravenous injection 0.2 ml/kg is used one time for cardiac MRI assessment</description>
    <arm_group_label>Heart graft rejection</arm_group_label>
    <arm_group_label>No rejection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Orthotopic heart transplantation patients

          -  Endomyocardial biopsies &lt; 72h

          -  Estimated glomerular filtration ratio &gt;30ml/min (calculated by Cockcroft formula for
             patients age &lt; 65 yo or MDRD for patients age &gt;65 ans)

          -  Patients affiliated to French national health insurance

          -  For pre-menopausal female patients, negative pregnancy test

          -  Patient's consent form signature

          -  Patient with correct French writing and speaking comprehension

        Exclusion Criteria:

          -  Endomyocardial biopsies showing acute cellular rejection grade 1R or antibodies
             mediated rejection pAMR1

          -  Patient in need of renal dialysis

          -  Past history of allergic reaction or side effects after gadolinium infusion

          -  Hemodynamical instability

          -  MRI contra-indication (claustrophobia, ocular metallic objects, non MRI compatible
             cardiac device, neurological non RMI compatible device, osteosynthesis prosthesis
             older than 1980)

          -  Pregnant or breast feeding woman

          -  Patient participating to another clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arnaud GAY, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rouen University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2015</study_first_submitted>
  <study_first_submitted_qc>March 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2015</study_first_posted>
  <last_update_submitted>May 25, 2016</last_update_submitted>
  <last_update_submitted_qc>May 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

